Passage Bio
-$0.38 (-7.04%) As of 8:34 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.
About PASG
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.
CEO
Bruce A. Goldsmith
Employees
74
Headquarters
Philadelphia, Pennsylvania
Founded
2017
PASG Key Statistics
Market cap
271.62M
Price-Earnings ratio
—
Dividend yield
—
Average volume
269.73K
High today
$5.27
Low today
$5.00
Open price
$5.15
Volume
247.78K
52 Week high
$30.14
52 Week low
$5.00
Analyst ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
PASG Earnings
-$0.90
-$0.60
-$0.30
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 3, Pre-Market